Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-23-070841

Director sold 18,978 shares at an average $39.99 ($758,983)

  • Director acquired 14,402 shares (option exercise)
  • Director gave up 3,022 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2023-12-13 Option exercise +6,378 $9.85 $62,823 29,951 D: show line 1 in the form
PATOU GARY Director 2023-12-13 Shares withheld for taxes −1,278 $39.68 $50,711 28,673 D: show line 2 in the form
PATOU GARY Director 2023-12-13 Sale −5,100 $38.94 $198,594 23,573 D: show line 3 in the form
PATOU GARY Director 2023-12-13 Option exercise +2,880 $9.85 $28,368 26,453 D: show line 4 in the form
PATOU GARY Director 2023-12-13 Shares withheld for taxes −577 $39.68 $22,895 25,876 D: show line 5 in the form
PATOU GARY Director 2023-12-13 Sale −2,303 $39.10 $90,047 23,573 D: show line 6 in the form
PATOU GARY Director 2023-12-13 Option exercise +5,144 $9.00 $46,296 28,717 D: show line 7 in the form
PATOU GARY Director 2023-12-13 Shares withheld for taxes −1,167 $39.68 $46,307 27,550 D: show line 8 in the form
PATOU GARY Director 2023-12-13 Sale −3,977 $39.84 $158,444 23,573 D: show line 9 in the form
PATOU GARY Director 2023-12-13 Sale −7,598 $41.05 $311,898 4,902 I: show line 10 in the form
Open-market sales · 18,978 sh · avg $39.99 · $758,983

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PATOU GARY Director 2023-12-13 Option exercise · Stock Option (Right to Buy) −6,378 0 D: show line 11 in the form
PATOU GARY Director 2023-12-13 Option exercise · Stock Option (Right to Buy) −2,800 0 D: show line 12 in the form
PATOU GARY Director 2023-12-13 Option exercise · Stock Option (Right to Buy) −5,144 0 D: show line 13 in the form
Loading xslF345X05/ownership.xml…